https://angionautix.com/wp-content/uploads/2021/05/noticia1dest.jpg
400
710
Estela
https://angionautix.com/wp-content/uploads/2021/04/logo-ANGIONAUTIX_ok.png
Estela2021-05-27 10:32:342024-11-19 11:24:52The 0-TICI-0 registry is currently in the analysis phase of the results after the recruitment has been completed.News
https://angionautix.com/wp-content/uploads/2021/05/noticia1dest.jpg
400
710
Estela
https://angionautix.com/wp-content/uploads/2021/04/logo-ANGIONAUTIX_ok.png
Estela2021-05-27 10:32:342024-11-19 11:24:52The 0-TICI-0 registry is currently in the analysis phase of the results after the recruitment has been completed.
Angionautix officially opens business in Mexico
NewsAngionautix officially opens business in Mexico through Angionautix Mexico S de RL CV.

Angionautix closes an exclusive distribution agreement for MIVI Neuroscience, Inc.
NewsAngionautix closes an exclusive distribution agreement for MIVI Neuroscience, Inc. products in Spain and Portugal

Angionautix closes an exclusive distribution agreement with Shape Memory Medical
NewsShape Memory Medical is dedicated to developing innovative therapeutic solutions for the cardiovascular and neurovascular markets. We are the first medical device company to introduce an FDA approved medical device using shape memory polymer (SMP) technology to a vascular market

CUSTOMER SUPPORT
Calle Valportillo II, nº14 Planta 2
28108, Alcobendas, Madrid

